Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 27:13:820572.
doi: 10.3389/fmicb.2022.820572. eCollection 2022.

Phage Revolution Against Multidrug-Resistant Clinical Pathogens in Southeast Asia

Affiliations
Review

Phage Revolution Against Multidrug-Resistant Clinical Pathogens in Southeast Asia

Mark B Carascal et al. Front Microbiol. .

Abstract

Southeast Asia (SEA) can be considered a hotspot of antimicrobial resistance (AMR) worldwide. As recent surveillance efforts in the region reported the emergence of multidrug-resistant (MDR) pathogens, the pursuit of therapeutic alternatives against AMR becomes a matter of utmost importance. Phage therapy, or the use of bacterial viruses called bacteriophages to kill bacterial pathogens, is among the standout therapeutic prospects. This narrative review highlights the current understanding of phages and strategies for a phage revolution in SEA. We define phage revolution as the radical use of phage therapy in infectious disease treatment against MDR infections, considering the scientific and regulatory standpoints of the region. We present a three-phase strategy to encourage a phage revolution in the SEA clinical setting, which involves: (1) enhancing phage discovery and characterization efforts, (2) creating and implementing laboratory protocols and clinical guidelines for the evaluation of phage activity, and (3) adapting regulatory standards for therapeutic phage formulations. We hope that this review will open avenues for scientific and policy-based discussions on phage therapy in SEA and eventually lead the way to its fullest potential in countering the threat of MDR pathogens in the region and worldwide.

Keywords: Southeast Asia; bacteriophage; multidrug resistance; phage revolution; phage therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Number and types of original research articles on phages published in SEA and indexed in PubMed from 2011 to 2021.
Figure 2
Figure 2
A three-phase strategy for implementing a phage revolution, with perspectives for SEA.

References

    1. Abdulamir A. S., Jassim S. A., Hafidh R. R., Bakar F. A. (2015). The potential of bacteriophage cocktail in eliminating methicillin-resistant Staphylococcus aureus biofilms in terms of different extracellular matrices expressed by PIA, ciaA-D and FnBPA genes. Ann. Clin. Microbiol. Antimicrob. 14:49. doi: 10.1186/s12941-015-0106-0, PMID: - DOI - PMC - PubMed
    1. Adamu Ahmad K., Sabo Mohammed A., Abas F. (2016). Chitosan nanoparticles as carriers for the delivery of ΦKAZ14 bacteriophage for oral biological control of colibacillosis in chickens. Molecules 21:256. doi: 10.3390/molecules21030256, PMID: - DOI - PMC - PubMed
    1. Ahmad K. A., Mohanmmed A. S., Abas F., Chin S. C. (2015). T4-like coliphage ΦKAZ14 virulent to pathogenic and extended spectrum β-lactamase-producing Escherichia coli of poultry origin. Virol. Sin. 30, 73–75. doi: 10.1007/s12250-014-3541-8, PMID: - DOI - PMC - PubMed
    1. Aklilu E., Raman K. (2020). MCR-1 gene encoded colistin-resistant Escherichia coli in raw chicken meat and bean sprouts in Malaysia. Int. J. Microbiol. 2020:8853582. doi: 10.1155/2020/8853582, PMID: - DOI - PMC - PubMed
    1. Al-Fendi A., Shueb R. H., Ravichandran M., Yean C. Y. (2014). Isolation and characterization of lytic vibriophage against Vibrio cholerae O1 from environmental water samples in Kelantan, Malaysia. J. Basic Microbiol. 54, 1036–1043. doi: 10.1002/jobm.201300458, PMID: - DOI - PubMed